XML 52 R36.htm IDEA: XBRL DOCUMENT

Note 14 - Parent Company Financial Statements (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2023

Condensed Balance Sheet [Table Text Block]

	*2023*			*2022*
Assets
Current assets
Cash and cash equivalents	$	1,454		$	286
Receivables due from subsidiaries		110,083			98,780
Prepaid expenses		437			611
Other current assets		12			7
Total current assets		111,986			99,684

Investment in Aemetis Property Keyes, Inc.		1,556			1,274
Investment in Aemetis International, Inc.		12,059			6,659
Investment in Aemetis Advanced Products Riverbank, Inc.		638			173
Investment in AE Advanced Products Keyes , Inc.		246			-
Total investments in Subsidiaries, net of advances		14,499			8,106

Property, plant and equipment, net		149			135
Other assets		2,096			2,377
Total Assets	$	128,730		$	110,302

Liabilities & stockholders' deficit
Current liabilities
Accounts payable	$	3,633		$	2,934
Mandatorily redeemable Series B convertible preferred		4,521			4,082
Other current liabilities		5,031			4,269
Total current liabilities		13,185			11,285

Long term liabilities:
Operating lease liability		1,716			2,047
Subsidiary obligation in excess of investment
Investment in AE Advanced Fuels, Inc.		220,571			177,856
Investment in Aemetis Americas, Inc		202			205
Investment in Aemetis Biofuels, Inc.		2,721			2,738
Investment in Aemetis Technologies, Inc.		4,868			4,716
Investment in AE Advanced Products Keyes , Inc.		-			270
Investment in Aemetis Health Products, Inc.		2,084			2,076
Investment in Goodland Advanced Fuels, Inc.		22,982			16,869
Investment in Aemetis Biogas LLC		70,471			91,292
Investment in Aemetis Carbon Capture Inc		5,895			2,323
Investment in Aemetis Properties Riverbank, Inc.		1,012			479
Total subsidiary obligation in excess of investment		330,806			298,824

Total long term liabilities		332,522			300,871

Stockholders' deficit
Series B Preferred convertible stock		-			1
Common stock		41			36
Additional paid-in capital		264,058			232,546
Accumulated deficit		(475,405	)		(428,985	)
Accumulated other comprehensive loss		(5,671	)		(5,452	)
Total stockholders' deficit		(216,977	)		(201,854	)
Total liabilities & stockholders' deficit	$	128,730		$	110,302

Condensed Income Statement [Table Text Block]

	*2023*			*2022*

Equity in subsidiary losses	$	(25,370	)	$	(91,561	)
Selling, general and administrative expenses		19,218			15,203

Operating loss		(44,588	)		(106,764	)
Other (income) expense
Interest expense		1,073			806
Debt related fees and amortization expense		781			1,581
Other income		(30	)		(1,400	)

Loss before income taxes		(46,412	)		(107,751	)

Income tax expense		8			7
Net loss		(46,420	)		(107,758	)

Other comprehensive loss
Foreign currency translation adjustment		(219	)		(1,102	)
Comprehensive loss	$	(46,639	)	$	(108,860	)

Condensed Cash Flow Statement [Table Text Block]

	*2023*			*2022*
Operating activities:
Net loss		(46,420	)		(107,758	)
Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation		7,660			6,410
Depreciation		51			29
Debt related fees and amortization expense		782			1,776
Subsidiary portion of net losses		25,370			91,561
Gain on litigation		-			(1,400	)
Warrants issued for working capital agreement		409			-
Changes in assets and liabilities:
Prepaid expenses		(608	)		111
Accounts payable		699			(90	)
Accrued interest expense		785			778
Other liabilities		85			(4,625	)
Other assets		276			207
Net cash used in operating activities		(10,911	)		(13,001	)

Investing activities:
Capital expenditures		(65	)		(128	)
Subsidiary advances, net		(9,707	)		1,222
Net cash provided by (used in) investing activities		(9,772	)		1,094

Financing activities:
Proceeds from the exercise of stock options		133			206
Proceeds from issuance of common stock in equity offering		21,718			11,987
Net cash provided by financing activities		21,851			12,193

Net increase in cash, cash equivalents, and restricted cash		1,168			286
Cash, cash equivalents and restricted cash at beginning of period		286			-
Cash, cash equivalents, and restricted cash at end of period	$	1,454		$	286

Supplemental disclosures of cash flow information, cash paid:
Income taxes paid		7			7

Supplemental disclosures of cash flow information, non-cash transactions:

Fair value of warrants issued to subordinated debt holders		1,278			1,939
Fair value of stock issued to a related party for guarantee fees		-			2,012
Fair value of warrants issued for capital expenditures		318			-
Fair value of warrants issued to lender for debt issuance costs		-			3,158
Fair value of stock issued to lender		-			1,335